Adam Maeder

Work

Analyst Adam Maeder works at PIPER SANDLER and is focused on the Healthcare sector with 392 price targets and ratings documented since 2019 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 55.17% with an average time for price targets to be met of 57.43 days.

Most recent stock forecast was given on NYXH, at 09-Nov-2022.

Adam Maeder best performing recommendations are on XENT.
The best stock recommendation documented was for SILK (SILK ROAD MEDICAL, INC) at 1/13/2021. The price target of $58 was fulfilled within 1 day with a profit of $2.98 (5.42%) receiving and performance score of 54.16.

Average potential price target upside

APEN AXNX EW INSP ISRG LIVN NVRO SILK STIM STXS SWAV TCMD XENT NYXH
APEN AXNX EW INSP ISRG LIVN NVRO SILK STIM STXS SWAV TCMD XENT NYXH